Taylor & Francis
Expert Review of Anticancer Therapy
,  volume 21 ,  issue 10 ,  pages 1081-1088

Avapritinib in unresectable or metastatic gastrointestinal stromal tumor with PDGFRA exon 18 mutation: safety and efficacy

Publication type: Journal Article
Publication date: 2021-08-22
Taylor & Francis
scimago Q2
wos Q2
SJR: 0.926
CiteScore: 5.2
Impact factor: 2.8
ISSN: 14737140, 17448328
Oncology
Pharmacology (medical)
Found 
Found 

Top-30

Journals

1
ChemistrySelect
ChemistrySelect, 1, 12.5%
ChemistrySelect
1 publication, 12.5%
Cancers
Cancers, 1, 12.5%
Cancers
1 publication, 12.5%
British Journal of Clinical Pharmacology
British Journal of Clinical Pharmacology, 1, 12.5%
British Journal of Clinical Pharmacology
1 publication, 12.5%
RSC Medicinal Chemistry
RSC Medicinal Chemistry, 1, 12.5%
RSC Medicinal Chemistry
1 publication, 12.5%
Pharmaceutics
Pharmaceutics, 1, 12.5%
Pharmaceutics
1 publication, 12.5%
Current Issues in Molecular Biology
Current Issues in Molecular Biology, 1, 12.5%
Current Issues in Molecular Biology
1 publication, 12.5%
1

Publishers

1
2
3
MDPI
MDPI, 3, 37.5%
MDPI
3 publications, 37.5%
Wiley
Wiley, 2, 25%
Wiley
2 publications, 25%
Royal Society of Chemistry (RSC)
Royal Society of Chemistry (RSC), 1, 12.5%
Royal Society of Chemistry (RSC)
1 publication, 12.5%
Elsevier
Elsevier, 1, 12.5%
Elsevier
1 publication, 12.5%
Springer Nature
Springer Nature, 1, 12.5%
Springer Nature
1 publication, 12.5%
1
2
3
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
8
Share
Cite this
GOST |
Cite this
GOST Copy
Henriques Abreu M., Serrano C. Avapritinib in unresectable or metastatic gastrointestinal stromal tumor with PDGFRA exon 18 mutation: safety and efficacy // Expert Review of Anticancer Therapy. 2021. Vol. 21. No. 10. pp. 1081-1088.
GOST all authors (up to 50) Copy
Henriques Abreu M., Serrano C. Avapritinib in unresectable or metastatic gastrointestinal stromal tumor with PDGFRA exon 18 mutation: safety and efficacy // Expert Review of Anticancer Therapy. 2021. Vol. 21. No. 10. pp. 1081-1088.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1080/14737140.2021.1963235
UR - https://doi.org/10.1080/14737140.2021.1963235
TI - Avapritinib in unresectable or metastatic gastrointestinal stromal tumor with PDGFRA exon 18 mutation: safety and efficacy
T2 - Expert Review of Anticancer Therapy
AU - Henriques Abreu, Miguel
AU - Serrano, César
PY - 2021
DA - 2021/08/22
PB - Taylor & Francis
SP - 1081-1088
IS - 10
VL - 21
PMID - 34404327
SN - 1473-7140
SN - 1744-8328
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2021_Henriques Abreu,
author = {Miguel Henriques Abreu and César Serrano},
title = {Avapritinib in unresectable or metastatic gastrointestinal stromal tumor with PDGFRA exon 18 mutation: safety and efficacy},
journal = {Expert Review of Anticancer Therapy},
year = {2021},
volume = {21},
publisher = {Taylor & Francis},
month = {aug},
url = {https://doi.org/10.1080/14737140.2021.1963235},
number = {10},
pages = {1081--1088},
doi = {10.1080/14737140.2021.1963235}
}
MLA
Cite this
MLA Copy
Henriques Abreu, Miguel, et al. “Avapritinib in unresectable or metastatic gastrointestinal stromal tumor with PDGFRA exon 18 mutation: safety and efficacy.” Expert Review of Anticancer Therapy, vol. 21, no. 10, Aug. 2021, pp. 1081-1088. https://doi.org/10.1080/14737140.2021.1963235.